ClinicalTrialsFinder
RecruitingPhase 2NCT05181891

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Sponsor

Washington State University

Enrollment

205 participants

Start Date

Jul 11, 2022

Study Type

INTERVENTIONAL

Conditions

Nicotine Use DisorderAlcohol Use Disorder (AUD)

Summary

Using a randomized controlled trial (RCT), the goal of this study is to evaluate the ability of evidence based behavioral treatment (contingency management: CM) to significantly decrease alcohol use and cigarette smoking among treatment-seeking smokers with an alcohol use disorder (AUD) who have initiated pharmacotherapy (varenicline; VC) for smoking cessation.

Eligibility

Min Age: 18 Years

Inclusion Criteria11

  • 4 or more standard drinks on the same occasion for women (5 or more standard drinks on the same occasion for men) on at least 4 occasions in the prior 30 days
  • Seeking AUD treatment
  • Seeking smoking cessation treatment
  • Aged 18+ years
  • DSM-5 diagnosis of AUD
  • Currently smoking daily according to PhenX Smoking Status (100 or more lifetime cigarettes plus current daily smoking)
  • Ability to read and speak English
  • Ability to provide written informed consent
  • Breath alcohol of 0.00 during informed consent
  • Provision of at least 1 EtG-positive urine test at any time during the induction period and at least one COT-positive urine test at any time during the induction period; and
  • Attended at least 4 of 6 possible visits during the induction period.

Exclusion Criteria5

  • Significant risk of dangerous alcohol withdrawal, defined as a history of alcohol detoxification or seizure in the last 12 months and expression of concern by the participant about dangerous withdrawal
  • Currently receiving any pharmacotherapy for alcohol
  • Currently receiving any pharmacotherapy for smoking
  • No suicide attempt in the last 20 years and
  • Any other medical (discernable by initial blood tests) or psychiatric condition that Drs. Layton or Rodin determine would compromise safe participation.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALContingency Management

Incentives for submitting negative-alcohol urine samples

BEHAVIORALNon-contingent control

Incentives for submitting urine samples

Locations(1)

Washington State University

Spokane, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05181891

Related Trials

MPFC Theta Burst Stimulation as a Treatment Tool for Alcohol Use Disorder: Effects on Drinking and Incentive Salience

NCT049989161 location

Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide

NCT070405921 location

Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community

NCT068037063 locations

Alpha-1 Blockade for Alcohol Use Disorder (AUD)

NCT041358461 location

Smoking Cessation and Menstrual Cycle Phase

NCT055153541 location